CDKN2A and synovial sarcoma: CDKN2A deletion is a highly frequent event in synovial sarcomas (58); moreover, the translocation facilitates repression of CDKN2A activity (59) and increases the expression of CDK4 as well as multiple cyclins (D1, B1, A2, I, and F) (60).